Saab 2015.
Methods |
Trial design: RCT Trial grouping: parallel groups Ethics and informed consent: not stated Follow‐up period: not stated Sample size estimate: not stated ITT analysis: yes; number randomised: 80; number analysed: 80 Funding: not stated |
|
Participants |
Inclusion criteria:
Exclusion criteria:
Pretreatment:
|
|
Interventions |
Intervention group:
Control group:
|
|
Outcomes |
PU incidence
|
|
Identification |
Sponsorship source: not reported Country: USA Setting: surgical ICU Comments: no comment Author's name: I Saab Institution: Henry Ford Hospital Email: not provided Address: 2799 West Grand Boulevard, Detroit, MA 48202 |
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Sequence generation not stated |
Allocation concealment (selection bias) | Unclear risk | Not stated |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Open‐label |
Blinding of outcome assessment (detection bias) All outcomes | High risk | Open‐label |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Outcomes reported for those randomised to each group |
Selective reporting (reporting bias) | Low risk | PU incidence reported |
Other bias | Unclear risk | As this is an abstract, this element is unclear |